4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-13-000968
Director bought 25,000 shares at $0.66 ($16,550)
- Director acquired 1,503,570 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Brauser Michael · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-05-10 | Option exercise : show line 1 in the form | +1,160,713 | $0.21 | $243,750 | 3,378,567 | I |
| 2013-05-13 | Option exercise : show line 2 in the form | +342,857 | $0.21 | $72,000 | 3,721,424 | I |
| 2013-05-13 | Purchase : show line 3 in the form | +25,000 | $0.66 | $16,550 | 4,519,926 | D |
| Open-market purchases · 25,000 sh · avg $0.66 · $16,550 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-05-10 | Option exercise : show line 4 in the form Warrants to Purchase Common Stock | −1,160,713 | $0.21 | 2013-05-20 | 1,160,713 | 342,857 | I |
| 2013-05-13 | Other disposition : show line 5 in the form Warrants to Purchase Common Stock | −342,857 | $0.21 | 2013-05-20 | 342,857 | 0 | I |
| 2013-05-13 | Other acquisition : show line 6 in the form Warrants to Purchase Common Stock | +342,857 | $0.21 | 2013-05-20 | 342,857 | 342,857 | I |
| 2013-05-13 | Option exercise : show line 7 in the form Warrants to Purchase Common Stock | −342,857 | $0.21 | 2013-05-20 | 342,857 | 0 | I |
Loading xslF345X03/form4-05142013_090530.xml…